4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01413139
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT01413139
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Germany
- Registry status
- Completed
Technical summary
Registry record NCT01413139. Allocation not applicable; no masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2011-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial Stenotic Disease
- Acronym
- 4-EVER
- Condition
- Peripheral Vascular Disease
- Condition
- Claudication
- Intervention (Device)
- 4F portfolio products from Biotronik
- Lead sponsor
- Flanders Medical Research Program
Record details
- Record id
cardio:ct-nct01413139- Content hash
dcad5d76ff34e348c82eaecd39666841ee64b663057b2f61112860d9e6aea16d